Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4409-4423
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4409
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4409
Figure 1 Screening flowchart for aggressive gastrointestinal non-Hodgkin lymphoma.
NHL: Non-Hodgkin lymphoma; PGI: Primary gastrointestinal; GI: Gastrointestinal; MALT: Mucosal associated lymphoid tissue; FL: Follicular cell lymphoma; MCL: Mantle cell lymphoma; DLBCL: Diffuse large B-cell lymphoma; BL: Burkitt’s lymphoma; PGI-TNKL: Primary gastrointestinal T/NK cell lymphomas; ITCL: Intestinal T-cell lymphoma; ENKTCL: Extranodal natural killer T cell lymphoma.
- Citation: Liu XH, Chen G, Cao DD, Liu H, Ke XK, Hu YG, Tan W, Ke D, Xu XM. Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas. World J Gastrointest Oncol 2024; 16(11): 4409-4423
- URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4409.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4409